Mersana Therapeutics
(NASDAQ:MRSN)
Mersana Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Mersana Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$7.57
0.12[1.61%]
At close: Aug 12
$7.63
0.0600[0.79%]
After Hours: 7:25PM EDT
Day High/Low7.5 - 7.93
52 Week High/Low2.68 - 8.02
Open / Close7.5 / 7.57
Float / Outstanding96.4M / 97.2M
Vol / Avg.1.1M / 1.5M
Mkt Cap735.6M
P/E-
50d Avg. Price4.91
Div / Yield-
Payout Ratio-
EPS-0.55
Total Float96.4M

Mersana Therapeutics (NASDAQ:MRSN), Quotes and News Summary

Mersana Therapeutics (NASDAQ: MRSN)

Day High/Low7.5 - 7.93
52 Week High/Low2.68 - 8.02
Open / Close7.5 / 7.57
Float / Outstanding96.4M / 97.2M
Vol / Avg.1.1M / 1.5M
Mkt Cap735.6M
P/E-
50d Avg. Price4.91
Div / Yield-
Payout Ratio-
EPS-0.55
Total Float96.4M
Sector: Health Care.Industry: Biotechnology
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. The Company's early stage programs include XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Mersana Therapeutics Questions & Answers

Q
How do I buy Mersana Therapeutics (MRSN) stock?
A

You can purchase shares of Mersana Therapeutics (NASDAQ: MRSN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Mersana Therapeutics's (MRSN) competitors?
Q
What is the target price for Mersana Therapeutics (MRSN) stock?
A

The latest price target for Mersana Therapeutics (NASDAQ: MRSN) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MRSN to fall to within 12 months (a possible -47.16% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Mersana Therapeutics (MRSN)?
A

The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $7.57 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Mersana Therapeutics (MRSN) pay a dividend?
A

The next Mersana Therapeutics (MRSN) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?
A

Mersana Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Mersana Therapeutics (MRSN) going to split?
A

There is no upcoming split for Mersana Therapeutics.

Q
What sector and industry does Mersana Therapeutics (MRSN) operate in?
A

Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.